AmberGen awarded 2-year Phase II SBIR grant for use of photocleavable peptide and peptoid bead-libraries in screening biomolecular interactions
AmberGen awarded 3-year Phase II SBIR grant from NIH-NIAID for development of a multiplex in vitro pediatric allergy test
Paper published in Rapid Communications in Mass Spectrometry “Correlated matrix-assisted laser desorption/ionization mass spectrometry and fluorescent imaging of photocleavable peptide-coded random bead-arrays” describing proteomic applications of Bead-AMS™ https://www.ncbi.nlm.nih.gov/pubmed/24285390
Paper published in Journal of Immunological Methods “Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer” detailing the development of a serological assay for colorectal cancer biomarkers based on the novel use of the VeraCode™ multiplex bead assay system https://www.ncbi.nlm.nih.gov/pubmed/24161315
AmberGen receives US Patent 8,507,648 for novel method of detecting protease activity using mass spectrometry
AmberGen receives US Patent 8,486,634 for novel method of detecting DNA methylation using solid-phase PCR
AmberGen receives US Patent 8,481,263 for creating self-assembled bead-protein libraries by solid-phase PCR and nascent protein expression
AmberGen receives US Patent 8,288,098 for a novel method of DNA sequencing using nucleotides having cleavable detectable labels
AmberGen receives US Patent 8,278,045 for detecting chain truncation mutations which cause breast and colorectal cancer
AmberGen awarded Phase I SBIR grant for the application of photocleavable bead technology to glycomics
